menu
    • menu

    Company profile for Adocia

    NEW Drugs in Dev: 11
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safet...
    Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdociaFrance Flag
    Country
    Country
    France
    Address
    Address
    115 avenue Lacassagne, LYON, 69003
    Telephone
    Telephone
    33 (0)4 72 610 610
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adocia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ADOCIA Reports Q1 2026 Financials And Business Update
    ADOCIA Reports Q1 2026 Financials And Business Update

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512630007/en/ADOCIA-Reports-First-Quarter-2026-Financial-Results-and-Provides-a-Business-Update

    BUSINESSWIRE
    12 May 2026
    Share Share
    Adocia: Shares and Voting Rights as of April 30, 2026
    Adocia: Shares and Voting Rights as of April 30, 2026

    07 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-07/number-of-shares-and-voting-rights-of-adocia-as-of-april-30-2026

    PHARMIWEB
    07 May 2026
    Share Share
    ADOCIA Unveils 2025 Financial Results And Corporate Update
    ADOCIA Unveils 2025 Financial Results And Corporate Update

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/adocia-announces-full-year-2025-financial-results-and-provides-a-corporate-and-financial-update

    PHARMIWEB
    21 Apr 2026
    Share Share
    Adocia Reports Shares, Voting Rights as of March 31, 2026
    Adocia Reports Shares, Voting Rights as of March 31, 2026

    10 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-10/number-of-shares-and-voting-rights-of-adocia-as-of-march-31st-2026

    PHARMIWEB
    10 Apr 2026
    Share Share
    Adocia's Shares And Voting Rights Update As Of Feb. 28, 2026
    Adocia's Shares And Voting Rights Update As Of Feb. 28, 2026

    06 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-06/number-of-shares-and-voting-rights-of-adocia-as-of-february-28th-2026

    PHARMIWEB
    06 Mar 2026
    Share Share
    ADOCIA Unveils Q4 2025 Financials And Business Update
    ADOCIA Unveils Q4 2025 Financials And Business Update

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/adocia-reports-fourth-quarter-2025-financial-results-and-provides-a-business-update

    PHARMIWEB
    24 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search